Concepedia

Jennifer D’Arrigo

JD

Statistics

Publications

3

Citations

128

H-Index

3

Active since

2003

Affiliations

Ligand Pharmaceuticals (United States)(Current)

Eli Lilly (United States)

Jennifer D’Arrigo is an author at Ligand Pharmaceuticals (United States) specializing in ligand binding, pharmacology, and molecular pharmacology.

Publications per year

2003–2005

3

Publications

3

Biological Characterization of a Heterodimer-Selective Retinoid X Receptor Modulator: Potential Benefits for the Treatment of Type 2 Diabetes

Mark D. Leibowitz, Robert Ardecky, Marcus F. Boehm et al. · Endocrinology · 2005 · 70 citations · Full text

, , +15

Design, Synthesis, and Structure−Activity Relationship Studies of Novel 6,7-Locked-[7-(2-alkoxy-3,5-dialkylbenzene)-3-methylocta]-2,4,6-trienoic Acids

Pierre‐Yves Michellys, Robert Ardecky, Jyun‐Hung Chen et al. · Journal of Medicinal Chemistry · 2003 · 33 citations · Full text

, , +13

Design, synthesis and structure–activity relationship of novel RXR-selective modulators

Pierre‐Yves Michellys, Jennifer D’Arrigo, Timothy A. Grese et al. · Bioorganic & Medicinal Chemistry Letters · 2004 · 25 citations · Full text

, , +10

1–3 of 3